USA - engelsk - NLM (National Library of Medicine)

renaissance ssa, llc - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see clinical pharmacology, adjunctive use in septic shock ). naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the other ingredients contained in the formulation. naloxone hydrochloride injection is an opioid antagonist. physical dependence associated with the use of naloxone hydrochloride injection has not been reported. tolerance to the opioid antagonist effect of naloxone is not known to occur.

USA - engelsk - NLM (National Library of Medicine)

renaissance ssa, llc - pentobarbital sodium (unii: njj0475n0s) (pentobarbital - unii:i4744080ir) - p a r e n t e r a l : - sedatives. - hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks (see “clinical pharmacology” section.) - preanesthetics. - anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics. barbiturates are contraindicated in patients with known barbiturate sensitivity. barbiturates are also contraindicated in patients with a history of manifest or latent porphyria. pentobarbital sodium injection is subject to control by the federal controlled substances act under dea schedule ii. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 milligrams (mg) of pen

USA - engelsk - NLM (National Library of Medicine)

renaissance ssa, llc - sodium nitroprusside (unii: eao03pe1tc) (nitroprusside - unii:169d1260km) - sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized. sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. sodium nitroprusside is also indicated for the treatment of acute congestive heart failure. sodium nitroprusside should not be used in the treatment of compensatory hypertension, where the primary hemodynamic lesion is aortic coarctation or arteriovenous shunting. sodium nitroprusside should not be used to produce hypotension during surgery in patients with known inadequate cerebral circulation, or in moribund patients (a.s.a. class 5e) coming to emergency surgery. patients with congenital (leber’s) optic atrophy or with tobacco amblyopia have unusually high cyanide/thiocyanate ratios. these rare condition

Singapore - engelsk - HSA (Health Sciences Authority)

transmedic pte ltd - general hospital - the renaissance spine module is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery. the renaissance brain module is indicated for precise positioning of surgical instruments during general brain surgery. the renaissance system may be used in open or minimally invasive or percutaneous procedures. renaissance 3d imaging capabilities provide a processing and conversion of 2d fluoroscopic projections from standard c-arms into volumetric 3d image. it is intended to be used whenever the clinician and/or patient benefits from generated 3d imaging of high contrast objects.

Israel - hebraisk - Ministry of Health

j-c health care ltd - esketamine as hydrochloride - esketamine as hydrochloride 28 mg/vial - esketamine

Singapore - engelsk - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - esketamine hcl 32.2mg eqv. to esketamine - spray - esketamine hcl 32.2mg eqv. to esketamine 28mg/vial

Israel - hebraisk - Ministry of Health

mazor surgical technologies - מומחה

Israel - hebraisk - Ministry of Health

mazor surgical technologies - מומחה

Italia - italiensk - Ministero della Salute

mazor robotics ltd - sistemi per chirurgia ortopedica stereotassica

USA - engelsk - NLM (National Library of Medicine)

insys therapeutics, inc. - fentanyl (unii: uf599785jz) (fentanyl - unii:uf599785jz) - fentanyl 0.1 mg - subsys is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking for one week or longer, around-the-clock medicine consisting of at least 60 mg of oral morphine per day, at least 25 mcg of transdermal fentanyl per hour, at least 30 mg of oral oxycodone per day, at least 8 mg of oral hydromorphone per day, or at least 25 mg oral oxymorphone per day, or at least 60mg oral hydrocodone per day, or an equianalgesic dose of another opioid daily for a week or longer. patients must remain on around-the-clock opioids when taking subsys. limitations of use: - not for use in opioid non-tolerant patients. - not for use in the management of acute or postoperative pain, including headache/migraine, dental pain, or in the emergency room [see contraindications ( 4)]. - as part of the transmuc